WT Wealth Management Has $4.89 Million Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

WT Wealth Management raised its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 5.6% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 56,690 shares of the company’s stock after purchasing an additional 3,030 shares during the period. VanEck Pharmaceutical ETF accounts for about 1.5% of WT Wealth Management’s holdings, making the stock its 18th biggest position. WT Wealth Management’s holdings in VanEck Pharmaceutical ETF were worth $4,891,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management lifted its position in VanEck Pharmaceutical ETF by 117.4% during the 4th quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 200,000 shares of the company’s stock worth $17,256,000 after acquiring an additional 108,000 shares during the last quarter. Adamsbrown Wealth Consultants LLC lifted its position in VanEck Pharmaceutical ETF by 102.3% during the 4th quarter. Adamsbrown Wealth Consultants LLC now owns 149,631 shares of the company’s stock worth $12,910,000 after acquiring an additional 75,659 shares during the last quarter. Thrivent Financial for Lutherans lifted its position in VanEck Pharmaceutical ETF by 33.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 234,890 shares of the company’s stock worth $22,322,000 after acquiring an additional 59,025 shares during the last quarter. Blue Chip Partners LLC acquired a new position in VanEck Pharmaceutical ETF during the 4th quarter worth $2,139,000. Finally, Miller Investment Management LP lifted its position in VanEck Pharmaceutical ETF by 13.4% during the 3rd quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock worth $19,722,000 after acquiring an additional 24,446 shares during the last quarter.

VanEck Pharmaceutical ETF Price Performance

VanEck Pharmaceutical ETF stock opened at $92.97 on Thursday. The firm has a fifty day moving average price of $88.05 and a two-hundred day moving average price of $91.46. VanEck Pharmaceutical ETF has a fifty-two week low of $84.48 and a fifty-two week high of $99.51. The firm has a market cap of $580.13 million, a price-to-earnings ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were paid a $0.411 dividend. The ex-dividend date of this dividend was Friday, December 27th. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.